More than 90,000 people are on the waiting list for a kidney in the U.S. Unfortunately, less than a third of those waiting ...
For those with kidney failure, the wait for a new kidney can take years. There just are not enough organs from deceased ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
New Hampshire native Tim Andrews was quite happy to spend his 67th birthday on Wednesday at Mass General Hospital (MGH). On ...
The former prom dates hadn’t been in touch in decades, but Elena Hershey decided to donate her kidney when she heard about ...
Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...
1d
Clinical Trials Arena on MSNBiogen begins dosing in trial of felzartamab for kidney transplant patients with AMRIn Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month ...
White are the first recipients of the Derek Forfang Patient Advocate Award. This award was established to honor Derek Forfang, who suffered from chronic kidney disease (CKD) and passed away due to ...
7d
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
Beyond AMR, Biogen is planning to initiate phase 3 trials of felzartamab in two kidney diseases, IgA nephropathy and primary ...
Dell Seton Medical Center opened a new, expanded clinic for its Adult Abdominal Transplant Center, which aims to provide ...
NEW YORK, March 5, 2025 /PRNewswire/ -- Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results